These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15625612)

  • 1. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
    Kahri J; Valkonen M; Bäcklund T; Vuoristo M; Kivistö KT
    Eur J Clin Pharmacol; 2005 Feb; 60(12):905-7. PubMed ID: 15625612
    [No Abstract]   [Full Text] [Related]  

  • 2. The statins: drug interactions of significance to the dental practitioner.
    Stevenson H; Longman LP; Randall C; Field EA
    Dent Update; 2006; 33(1):14-6, 18, 20. PubMed ID: 16512094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
    Castro JG; Gutierrez L
    Am J Med; 2002 Apr; 112(6):505. PubMed ID: 11959068
    [No Abstract]   [Full Text] [Related]  

  • 4. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
    Lewin JJ; Nappi JM; Taylor MH
    Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia associated with atorvastatin.
    Segal AS
    Am J Med; 2002 Aug; 113(2):171. PubMed ID: 12133763
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV.
    Mah Ming JB; Gill MJ
    AIDS Patient Care STDS; 2003 May; 17(5):207-10. PubMed ID: 12816614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
    Lau WC; Carville DG; Bates ER
    Circulation; 2004 Aug; 110(6):e66-7; author reply e66-7. PubMed ID: 15302813
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential statin-clopidogrel interaction requires more study.
    Williams D; Ford I; Hawksworth G
    Circulation; 2004 Aug; 110(6):e68; author reply e68. PubMed ID: 15302814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
    Franz CC; Bruggisser M; Krähenbühl S; Rätz Bravo AE
    Praxis (Bern 1994); 2011 Mar; 100(5):273-84. PubMed ID: 21365557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atorvastatin . A new generation of hypolipemic agents?].
    Azanza JR; Sádaba B; Quetglas EG
    Rev Med Univ Navarra; 1998; 42(1):51-5. PubMed ID: 10420957
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia.
    Negevesky GJ; Kolsky MP; Laureno R; Yau TH
    Arch Ophthalmol; 2000 Mar; 118(3):427-8. PubMed ID: 10721974
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves.
    Jiménez-Alonso J; Osorio JM; Gutiérrez-Cabello F; López de la Osa A; León L; Mediavilla García JD
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811-2. PubMed ID: 10448788
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological interactions of statins.
    Paoletti R; Corsini A; Bellosta S
    Atheroscler Suppl; 2002 May; 3(1):35-40. PubMed ID: 12044584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
    Shechter M
    Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of HMG-CoA reductase inhibitors: focus on atorvastatin.
    Bernini F; Poli A; Paoletti R
    Cardiovasc Drugs Ther; 2001; 15(3):211-8. PubMed ID: 11713888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].
    Rubí S; Duch J; Ortín J; Setoain X; Pons F
    Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790
    [No Abstract]   [Full Text] [Related]  

  • 19. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH; Seeger JD
    Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.